Skip Navigation
Department of Health and Human Services
Slide Tray
0 slides

Return to Slide Library


Add Presentation to Slide Tray Presentation:

Off-Label Use of Atypical Antipsychotics: An Update

Slide: 4 of 47

Introduction to Atypical Antipsychotics (2 of 4)

As of the date of this review, nine second-generation, atypical antipsychotic drugs have been approved by the U.S. Food and Drug Administration (FDA).

Aripiprazole (Abilify®)
Asenapine (Saphris®)
Clozapine (Clozaril®, FazaClo®)
Iloperidone (Fanapt®)
Olanzapine (Zyprexa®)
Paliperidone (Invega®)
Quetiapine (Seroquel®)
Risperidone (Risperdal®)
Ziprasidone (Geodon®)